Capital Catapult Fund Llc Sarissa serves as Executive at Iterum Therapeutics plc, where they oversee executive responsibilities. Since joining the company, Capital Catapult Fund Llc Sarissa has executed 3 insider transactions totaling $50.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 12, 2021 involved selling 10,619,949 shares valued at $24.1M.
Capital Catapult Fund Llc Sarissa currently holds 10,619,949 shares of Iterum Therapeutics plc (ITRM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Catapult Fund Llc Sarissa has been a net seller of ITRM stock. They have purchased $0 and sold $50.0M worth of shares.
Capital Catapult Fund Llc Sarissa's most recent insider trade was on Feb 12, 2021, when they sold 10,619,949 shares at $2.27 per share.
Get notified when new Form 4 filings are submitted
| $2.59 |
| Discretionary |
| Feb 11, 2021 | ITRM | $0 | Conversion | 20,619,949 | $N/A | Discretionary |